Market Overview

GlaxoSmithKline (GSK) Shares Rise With Upgrade


Shares of GlaxoSmithKline PLC (NYSE: GSK) were up more than 1% in morning trading after the company was upgraded by JP Morgan (NYSE: JPM) from Underweight to Neutral with a price target of $26.

The pharmaceutical company is adding 200 employees to its field force and is introducing several new products, some of them patent protected, over the next year to year and a half.

GlaxoSmithKline's 52 week range is $27.15 to $43.47.


Related Articles (GSK + JPM)

View Comments and Join the Discussion!

Posted-In: GlaxoSmithKline PLCAnalyst Color Long Ideas News Upgrades Markets Analyst Ratings Trading Ideas

Latest Ratings

VCELSVB LeerinkMaintains60.0
INGNSVB LeerinkMaintains54.0
TRHCSVB LeerinkMaintains43.0
RGENSVB LeerinkMaintains250.0
RDFNDA DavidsonMaintains92.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at